NR3C1 and multiple sclerosis: At high concentrations (e.g. 1 g/day methylprednisolone used in the treatment of multiple sclerosis), the physiological effects of steroids are mediated via the cell membrane-bound glucocorticoid receptors as well as via membrane stabilization.